Nano-X CEO buys 10,000 shares at $0.69
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nano-X Imaging Ltd. (NNOX) reports that Chief Executive Officer and director Erez Meltzer, through a wholly owned company, purchased 10,000 ordinary shares of the company on September 15, 2026 at $0.69 per share, increasing his indirectly held position to 65,443 shares. He also directly holds 60,584 ordinary shares and maintains stock options over 490,234 underlying shares at exercise prices between $2.21 and $23.84, with expirations from 2030 to 2034, some of which vest over time through April 16, 2028. No Rule 10b5-1 trading plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares F1 | 10,000 | $0.69 | $7K |
| Holding | Stock Option (right to buy ordinary shares) F2, F3 | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) F2, F4 | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) F2, F5 | -- | -- | -- |
| Holding | Ordinary Shares F2 | -- | -- | -- |
Footnotes (5)
- F1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
- F2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
- F4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
- F5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).
Key Figures
Key Terms
indirect ownership financial
fully vested and exercisable financial
exercise price financial
expiration date financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NNOX CEO Erez Meltzer report on this Form 4?
What Nano-X (NNOX) stock options does the CEO have at a $2.21 exercise price?
What higher-strike NNOX stock options are reported for the CEO?
Are the Nano-X (NNOX) CEO’s stock options fully vested?
AI-generated analysis. How Rhea-AI works. Not financial advice.